drugset / Trial / NCT05190315
Chlorpromazine and Standard of Care in Glioblastoma
NaSingle-groupOpen-labelTreatment
Summary
This is a phase 1 study investigating the re-purposing of chlorpromazine, combined with temozolomide and radiation in the treatment of newly diagnosed glioblastoma multiforme.
Timeline
- Start
- 2022-01-28
- Primary completion
- 2023-04-25
- Completion
- 2024-07-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chlorpromazine | Small molecule | 25 mg | Oral |
| Subject | Chlorpromazine | Small molecule | 50 mg | Oral |
| Background | Temozolomide | Small molecule | 200 mg/m2 | Oral |